Ines Pires daSilva

15PUBLICATIONS
93CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Oct 01, 2026
Five-year survival with neoadjuvant therapy in melanoma: updated pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC).

|May 27, 2026
Immunotherapy for early-stage cutaneous squamous cell carcinoma.

|May 04, 2026
Discontinuation of combo immunotherapy and outcome of patients with melanoma brain metastases.

|Mar 12, 2026
Molecular Profiling and Matched Targeted Therapy for Patients With Advanced Melanoma: Results From Part 1 of the MatchMEL Study.

Andrea Boutros, Matteo S Carlino, Raja Chaganti

|Nov 28, 2025
International real-world study of combination immunotherapy sequences in metastatic melanoma.

Mora Guardamagna, Sarah E Lochrin, James William Smithy

|Oct 08, 2025
Long-Term Outcomes and Toxicities in Patients With Metastatic Non-Small Cell Lung Cancer Treated With Immunotherapy Containing Regimens.

Meghana Maddula, Lauren J Brown, Venessa Chin

Pageof 3

Frequent Collaborators

10 joint publications

Serigne N Lo

7 joint publications

Georgina V Long

7 joint publications

Alexander Maxwell Menzies

7 joint publications

Richard A Scolyer